Reports on the efforts of British company PowderMed in developing a DNA vaccine for the avian flu. Reported deaths due to the flu; Advantage of developing DNA vaccines over traditional influenza vaccines; Results of the phase I clinical trial of a proprietary prophylactic DNA influenza vaccine.